Complex 3D Models to Study Drug Targeting of Invadopodia
Journal:
Clinical Cancer Drugs
Volume:
1
Page:
85-89
Author(s):
Njainday Pulo Jobe, Daniel Rosel, Ondrej Tolde, Jan Kosla and Jan Brabek
Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2346-2356
Author(s):
Joshua K. Ko and Kathy K. Auyeung
Personalized Peptide Vaccine for Treatment of Advanced Cancer
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2332-2345
Author(s):
Tetsuro Sasada, Akira Yamada, Masanori Noguchi and Kyogo Itoh
Angiotensin-(1-7): A Peptide Hormone with Anti-Cancer Activity
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2417-2423
Author(s):
P.E. Gallagher, A.L. Arter, G. Deng and E.A. Tallant
Potential Clinical Applications of Multi-functional Milk Proteins and Peptides in Cancer Management
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2424-2437
Author(s):
H. YF Chen, O. Mollstedt, Men-Hwei Tsai and R.B Kreider
Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2950-2977
Author(s):
Gabriella Testa, Fiorella Biasi, Giuseppe Poli and Elena Chiarpotto
Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2899-2911
Author(s):
Liangkun You, Changyu Liu, Hexiao Tang, Yongde Liao and Shengling Fu
Crosstalk between IGF-1R and other Tumor Promoting Pathways
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2912-2921
Author(s):
Changyu Liu, Zheng Zhang, Hexiao Tang, Zhixiao Jiang, Liangkun You and Yongde Liao
A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2648-2666
Author(s):
Lilia Alberghina, Daniela Gaglio, Rosa Maria Moresco, Maria Carla Gilardi, Cristina Messa and Marco Vanoni
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2881-2898
Author(s):
Christine Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger and Brigitte Marian